5 Followers on Owler

AMO Pharma

Read more
Ibraheem Mahmood's photo - Co-Founder & CEO of AMO Pharma

Co-Founder & CEO

Ibraheem Mahmood

CEO Approval Rating

90/100

Founded:

2015

Status:

PrivateIndependent Company

Est. Annual Revenue
$2M
Agree?
Est. Employees
20
Agree?

AMO Pharma Acquisitions

No recent acquisitions found related to AMO Pharma

AMO Pharma Funding History

Since AMO Pharma was founded in 2015, it has participated in 2 rounds of funding. In total AMO Pharma has raised $60.0M. AMO Pharma's last funding round was on Jan 2020 for a total of $35.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Jan 2020
$35M
-
Equity
Sep 2015
$25M
-

Since AMO Pharma was founded in 2015, it has participated in 2 rounds of funding. In total AMO Pharma has raised $60.0M. AMO Pharma's last funding round was on Jan 2020 for a total of $35.0M

AMO Pharma Investments

No recent investments found related to AMO Pharma

AMO Pharma News

February 28, 2020FinanzNachrichten

AMO Pharma to Present at Cowen and Company 40th Annual Health Care Conference

LONDON, Feb. 28, 2020 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmace... See more »
January 9, 2020FinanzNachrichten

AMO Pharma Announces Initiation of Planned Pivotal Clinical Trial for Myotonic Dystrophy Following $35m Fund Raise

Trial to assess AMO-02 in treatment of congenital myotonic dystrophy to begin patient enrollment in e... See more »
January 9, 2020firstwordpharma

AMO Pharma Announces Initiation of Planned Pivotal Clinical Trial for Myotonic Dystrophy Following $35m Fund Raise

LONDON, Jan. 9, 2020 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceu... See more »
September 16, 2019FinanzNachrichten

AMO Pharma Participates in Workshop on Central Nervous System Involvement in Progression and Treatment of Myotonic Dystrophy During Myotonic Dystrophy Foundation Annual Conference

Dr. Joe Horrigan, AMO Pharma CMO, joined with other global leaders in research and patient care to ad... See more »
June 13, 2019FinanzNachrichten

Updates on Development of AMO Pharma's AMO-02 Presented at International Myotonic Dystrophy Consortium Meeting

Professor Hanns Lochmüller from Children's Hospital of Eastern Ontario Research Institute highlighted... See more »
May 6, 2019FinanzNachrichten

AMO Pharma Presents Statistical Analysis of Results of Phase 2 Study of AMO-02 in Adolescents with Autism Spectrum Disorder

Results highlighting consistent patterns in efficacy across multiple outcomes measures presented at I... See more »
April 21, 2019Business Medical Dialogues

AMO Pharma launches clinician-completed rating scale for congenital myotonic dystrophy type 1

LONDON: AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rar... See more »

AMO Pharma Press Releases

October 26, 2016NewsMaker

Fragile X SyndromeTherapeutics Market Pipeline Review, H2 2016

Fragile X Syndrome - Pipeline Review, H2 2016, provides an overview of the Fragile X Syndrome pipelin... See more »
August 10, 2016PR Newswire

AMO Pharma Initiates Phase 2 Clinical Trial in UK for AMO-02 for Treatment of Congenital and Juvenile Onset Myotonic Dystrophy

Study represents first sponsor-led clinical research program for patients with congenital and juvenil... See more »

Social Media

AMO Pharma Headquarters

1 Park Row

Leeds, EnglandLS1 5AB

44-148-331-9070

Driving Directions »

Trending Companies

AMO Pharma Summary

ABOUT

Overview

AMO Pharma is developing new treatments for serious and debilitating diseases including rare genetic disorders. AMO Pharma was founded in 2015. AMO Pharma's headquarters is located in Leeds, England, GB LS1 5AB. It has raised 60.0M in 2 rounds. The la...

CEO

AMO Pharma's Co-Founder & CEO, Ibraheem Mahmood, currently has an approval rating of 90%. AMO Pharma's primary competitors are

Frequently Asked Questions about AMO Pharma

  1. When was AMO Pharma founded?

    AMO Pharma was founded in 2015
  2. Who is AMO Pharma's CEO?

    AMO Pharma's CEO is Ibraheem Mahmood
  3. How much revenue does AMO Pharma generate?

    AMO Pharma generates $2M in revenue
  4. How much funding does AMO Pharma have?

    AMO Pharma has historically raised $60M in funding
  1. Where is AMO Pharma's headquarters?

    AMO Pharma's headquarters is in Leeds England, GB
  2. How many employees does AMO Pharma have?

    AMO Pharma has 20 employees
  3. What sector does AMO Pharma operate in?

    AMO Pharma is in Biotechnology